Obesity and sexual health: focus on postmenopausal women

References

• Leeners B, Geary N, Tobler PN, et al. Ovarian hormones and obesity. Hum Reprod Update. 2017;23(3):300–321. doi: 10.1093/humupd/dmw045.
   PubMed Web of Science ®Google Scholar
• WHO defining obesity and overweight. [cited 2023 Jul 29]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
   Google Scholar
• Dai H, Alsalhe TA, Chalghaf N, et al. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990–2017: an analysis of the global burden of disease study. PLoS Med. 2020;17(7):e1003198. doi: 10.1371/journal.pmed.1003198.
   PubMed Web of Science ®Google Scholar
• Ahmad NN, Butsch WS, Aidarous S. Clinical management of obesity in women: addressing a lifecycle of risk. Obstet Gynecol Clin North Am. 2016;43(2):201–230. doi: 10.1016/j.ogc.2016.01.007.
   PubMed Web of Science ®Google Scholar
• Gill L, Mackey S. Obstetrician-gynecologists’ strategies for patient initiation and maintenance of antiobesity treatment with glucagon-like peptide-1 receptor agonists. J Womens Health (Larchmt). 2021;30(7):1016–1027. doi: 10.1089/jwh.2020.8683.
   PubMed Web of Science ®Google Scholar
• Cena H, Chiovato L, Nappi RE. Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists. J Clin Endocrinol Metab. 2020;105(8):e2695–e2709. doi: 10.1210/clinem/dgaa285.
   PubMed Web of Science ®Google Scholar
• Rowland DL, McNabney SM, Mann AR. Sexual function, obesity, and weight loss in men and women. Sex Med Rev. 2017;5(3):323–338. doi: 10.1016/j.sxmr.2017.03.006.
   PubMed Web of Science ®Google Scholar
• Williamson DA, Bray GA, Ryan DH. Is 5% weight loss a satisfactory criterion to define clinically significant weight loss? Obesity (Silver Spring). 2015;23(12):2319–2320. doi: 10.1002/oby.21358.
   PubMed Web of Science ®Google Scholar
• Jensen MD, Ryan DH, Apovian CM, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25_suppl_2):S102–S138. [Database] doi: 10.1161/01.cir.0000437739.71477.ee.
   PubMed Web of Science ®Google Scholar
• Smith GI, Mittendorfer B, Klein S. Metabolically healthy obesity: facts and fantasies. J Clin Invest. 2019;129(10):3978–3989. doi: 10.1172/JCI129186.
   PubMed Web of Science ®Google Scholar
• Tsatsoulis A, Paschou SA. Metabolically healthy obesity: criteria, epidemiology, controversies, and consequences. Curr Obes Rep. 2020;9(2):109–120. doi: 10.1007/s13679-020-00375-0.
   PubMed Web of Science ®Google Scholar
• Rey-López JP, de Rezende LF, Pastor-Valero M, et al. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obes Rev. 2014;15(10):781–790. doi: 10.1111/obr.12198.
   PubMed Web of Science ®Google Scholar
• Tanriover C, Copur S, Gaipov A, et al. Metabolically healthy obesity: misleading phrase or healthy phenotype? Eur J Intern Med. 2023;111:5–20. doi: 10.1016/j.ejim.2023.02.025.
   PubMed Web of Science ®Google Scholar
• Stefan N, Schulze MB. Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment. Lancet Diabetes Endocrinol. 2023;11(6):426–440. doi: 10.1016/S2213-8587(23)00086-4.
   PubMed Web of Science ®Google Scholar
• van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014;14(1):9. doi: 10.1186/1472-6823-14-9.
   PubMedGoogle Scholar
• Kabat GC, Wu WY, Bea JW, et al. Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women. Int J Obes (Lond). 2017;41(1):170–177. doi: 10.1038/ijo.2016.179.
   PubMed Web of Science ®Google Scholar
• Opoku AA, Abushama M, Konje JC. Obesity and menopause. Best Pract Res Clin Obstet Gynaecol. 2023;88:102348. doi: 10.1016/j.bpobgyn.2023.102348.
   PubMed Web of Science ®Google Scholar
• Gold EB, Crawford SL, Shelton JF, et al. Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Women’s Health Across the Nation (SWAN). Menopause. 2017;24(1):9–26. doi: 10.1097/GME.0000000000000723.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Chedraui P, Lambrinoudaki I, et al. Menopause: a cardiometabolic transition. Lancet Diabetes Endocrinol. 2022;10(6):442–456. doi: 10.1016/S2213-8587(22)00076-6.
   PubMed Web of Science ®Google Scholar
• Thomas HN, Thurston RC. A biopsychosocial approach to women’s sexual function and dysfunction at midlife: a narrative review. Maturitas. 2016;87:49–60. doi: 10.1016/j.maturitas.2016.02.009.
   PubMed Web of Science ®Google Scholar
• WHO defining sexual health. [cited 2023 Jul 29]. https://www.who.int/health-topics/sexual-health#tab=tab_1.
   Google Scholar
• Davis SR, Castelo-Branco C, Chedraui P, et al. Writing Group of the International Menopause Society for World Menopause Day 2012. Understanding weight gain at menopause. Climacteric. 2012;15(5):419–429. doi: 10.3109/13697137.2012.707385.
   PubMed Web of Science ®Google Scholar
• Simon JA, Davis SR, Althof SE, et al. Sexual well-being after menopause: an international menopause society white paper. Climacteric. 2018;21(5):415–427. doi: 10.1080/13697137.2018.1482647.
   PubMed Web of Science ®Google Scholar
• Pérez-López FR, Chedraui P, Gilbert JJ, et al. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women’s Health Initiative era. Fertil Steril. 2009;92(4):1171–1186. doi: 10.1016/j.fertnstert.2009.06.032.
   PubMed Web of Science ®Google Scholar
• Cipriani S, Simon JA. Sexual dysfunction as a harbinger of cardiovascular disease in postmenopausal women: how far are we? J Sex Med. 2022;19(9):1321–1332. doi: 10.1016/j.jsxm.2022.06.007.
   PubMed Web of Science ®Google Scholar
• Greendale GA, Sternfeld B, Huang M, et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019;4(5):e124865. doi: 10.1172/jci.insight.124865.
   PubMed Web of Science ®Google Scholar
• Greendale GA, Han W, Finkelstein JS, et al. Changes in regional fat distribution and anthropometric measures Across the menopause transition. J Clin Endocrinol Metab. 2021;106(9):2520–2534. doi: 10.1210/clinem/dgab389.
   PubMed Web of Science ®Google Scholar
• Pan R, Chen Y. Fat biology and metabolic balance: on the significance of sex. Mol Cell Endocrinol. 2021;533:111336. doi: 10.1016/j.mce.2021.111336.
   PubMed Web of Science ®Google Scholar
• Steiner BM, Berry DC. The regulation of adipose tissue health by estrogens. Front Endocrinol (Lausanne). 2022;13:889923. doi: 10.3389/fendo.2022.889923.
   PubMedGoogle Scholar
• Valencak TG, Osterrieder A, Schulz TJ. Sex matters: the effects of biological sex on adipose tissue biology and energy metabolism. Redox Biol. 2017;12:806–813. doi: 10.1016/j.redox.2017.04.012.
   PubMed Web of Science ®Google Scholar
• Lempesis IG, Hoebers N, Essers Y, et al. Distinct inflammatory signatures of upper and lower body adipose tissue and adipocytes in women with normal weight or obesity. Front Endocrinol (Lausanne). 2023;14:1205799. doi: 10.3389/fendo.2023.1205799.
   PubMed Web of Science ®Google Scholar
• Stubbins RE, Najjar K, Holcomb VB, et al. Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance. Diabetes Obes Metab. 2012;14(1):58–66. doi: 10.1111/j.1463-1326.2011.01488.x.
   PubMed Web of Science ®Google Scholar
• Gibson CJ, Thurston RC, El Khoudary SR, et al. Body mass index following natural menopause and hysterectomy with and without bilateral oophorectomy. Int J Obes (Lond). 2013;37(6):809–813. doi: 10.1038/ijo.2012.164.
   PubMed Web of Science ®Google Scholar
• Davis SR, Lambrinoudaki I, Lumsden M, et al. Menopause. Nat Rev Dis Primers. 2015;1(1):15004. doi: 10.1038/nrdp.2015.4.
   PubMedGoogle Scholar
• Liu XM, Chan HC, Ding GL, et al. FSH regulates fat accumulation and redistribution in aging through the Gαi/Ca(2+)/CREB pathway. Aging Cell. 2015;14(3):409–420. doi: 10.1111/acel.12331.
   PubMed Web of Science ®Google Scholar
• De Jesus AN, Henry BA. The role of oestrogen in determining sexual dimorphism in energy balance. J Physiol. 2023;601(3):435–449. doi: 10.1113/JP279501.
   PubMed Web of Science ®Google Scholar
• Rivera HM, Stincic TL. Estradiol and the control of feeding behavior. Steroids. 2018;133:44–52. doi: 10.1016/j.steroids.2017.11.011.
   PubMed Web of Science ®Google Scholar
• Oh H, Wild RA, Manson JE, et al. Obesity, height, and serum androgen metabolism among postmenopausal women in the women’s health initiative observational study. Cancer Epidemiol Biomarkers Prev. 2021;30(11):2018–2029. doi: 10.1158/1055-9965.EPI-21-0604.
   PubMed Web of Science ®Google Scholar
• Millán-de-Meer M, Luque-Ramírez M, Nattero-Chávez L, et al. PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis. Hum Reprod Update. 2023;29(6):741–772. doi: 10.1093/humupd/dmad015.
   PubMed Web of Science ®Google Scholar
• Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006;113(10):1148–1159. doi: 10.1111/j.1471-0528.2006.00990.x.
   PubMed Web of Science ®Google Scholar
• Fernandez CJ, Chacko EC, Pappachan JM. Male obesity-related secondary hypogonadism – pathophysiology, clinical implications and management. Eur Endocrinol. 2019;15(2):83–90. doi: 10.17925/EE.2019.15.2.83.
   PubMedGoogle Scholar
• Nappi RE, Cucinella L, Martella S, et al. Female sexual dysfunction (FSD): prevalence and impact on quality of life (QoL). Maturitas. 2016;94:87–91. doi: 10.1016/j.maturitas.2016.09.013.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Verde JB, Polatti F, et al. Self-reported sexual symptoms in women attending menopause clinics. Gynecol Obstet Invest. 2002;53(3):181–187. doi: 10.1159/000058371.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Albani F, Santamaria V, et al. Hormonal and psycho-relational aspects of sexual function during menopausal transition and at early menopause. Maturitas. 2010;67(1):78–83. doi: 10.1016/j.maturitas.2010.05.008.
   PubMed Web of Science ®Google Scholar
• Nappi RE. New attitudes to sexuality in the menopause: clinical evaluation and diagnosis. Climacteric. 2007;10 Suppl 2:105–108. doi: 10.1080/13697130701599876.
   PubMed Web of Science ®Google Scholar
• Cucinella L, Martini E, Tiranini L, et al. Menopause and female sexual dysfunctions. Minerva Obstet Gynecol. 2022;74(3):234–248. doi: 10.23736/S2724-606X.22.05001-1.
   PubMedGoogle Scholar
• Nappi RE, Cucinella L. Sexuality, pelvic floor/vaginal health and contraception at menopause. Best Pract Res Clin Obstet Gynaecol. 2022;81:85–97. doi: 10.1016/j.bpobgyn.2021.11.006.
   PubMed Web of Science ®Google Scholar
• Barbagallo F, Cucinella L, Tiranini L, et al. Relationship between personality traits and sexual function in symptomatic postmenopausal women. Maturitas. 2022;166:50–57. doi: 10.1016/j.maturitas.2022.08.010.
   PubMed Web of Science ®Google Scholar
• Thomas HN, Hess R, Thurston RC. Correlates of sexual activity and satisfaction in midlife and older women. Ann Fam Med. 2015;13(4):336–342. doi: 10.1370/afm.1820.
   PubMed Web of Science ®Google Scholar
• Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208.
   PubMed Web of Science ®Google Scholar
• Derogatis L, Clayton A, Lewis-D’Agostino D, et al. Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med. 2008;5(2):357–364. doi: 10.1111/j.1743-6109.2007.00672.x.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 2013). Diagnostic and statistical manual of mental disorders (5th ed.). doi: 10.1176/appi.books.9780890425596.
   Google Scholar
• McCabe MP, Sharlip ID, Atalla E, et al. Definitions of sexual dysfunctions in women and men: a consensus statement From the fourth international consultation on sexual medicine 2015. J Sex Med. 2016;13(2):135–143. doi: 10.1016/j.jsxm.2015.12.019.
   PubMed Web of Science ®Google Scholar
• Parish SJ, Hahn SR, Goldstein SW, et al. The international society for the study of women’s sexual health process of care for the identification of sexual concerns and problems in women. Mayo Clin Proc. 2019;94(5):842–856. doi: 10.1016/j.mayocp.2019.01.009.
   PubMed Web of Science ®Google Scholar
• Moon KH, Park SY, Kim YW. Obesity and erectile dysfunction: from bench to clinical implication. World J Mens Health. 2019;37(2):138–147. doi: 10.5534/wjmh.180026.
   PubMedGoogle Scholar
• Harlow SD, Karvonen-Gutierrez C, Elliott MR, et al. It is not just menopause: symptom clustering in the Study of Women’s Health Across the Nation. Womens Midlife Health. 2017;3(1):2. doi: 10.1186/s40695-017-0021-y.
   PubMedGoogle Scholar
• Shah MB. Obesity and sexuality in women. Obstet Gynecol Clin North Am. 2009;36(2):347–360, ix. ix. doi: 10.1016/j.ogc.2009.04.004.
   PubMed Web of Science ®Google Scholar
• Salari N, Hasheminezhad R, Sedighi T, et al. The global prevalence of sexual dysfunction in obese and overweight women: a systematic review and meta-analysis. BMC Womens Health. 2023;23(1):375. doi: 10.1186/s12905-023-02544-4.
   PubMed Web of Science ®Google Scholar
• Shifren JL, Monz BU, Russo PA, et al. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112(5):970–978. doi: 10.1097/AOG.0b013e3181898cdb.
   PubMed Web of Science ®Google Scholar
• Tserotas K, Blümel JE. Menopause research in Latin America. Climacteric. 2019;22(1):17–21. doi: 10.1080/13697137.2018.1540565.
   PubMed Web of Science ®Google Scholar
• Silva GMDD, Lima SMRR, Reis BFD, et al. Evaluation of obesity influence in the sexual function of postmenopausal women: a cross-sectional study. Rev Bras Ginecol Obstet. 2019;41(11):660–667. doi: 10.1055/s-0039-1700795.
   PubMedGoogle Scholar
• Kirchengast S, Hartmann B, Gruber D, et al. Decreased sexual interest and its relationship to body build in postmenopausal women. Maturitas. 1996;23(1):63–71. doi: 10.1016/0378-5122(95)00954-x.
   PubMed Web of Science ®Google Scholar
• Llaneza P, Iñarrea J, Gonzalez C, et al. Differences in health related quality of life in a sample of spanish menopausal women with and without obesity. Maturitas. 2007;58(4):387–394. doi: 10.1016/j.maturitas.2007.09.013.
   PubMed Web of Science ®Google Scholar
• Tang R, Fan Y, Luo M, et al. General and central obesity are associated With increased severity of the VMS and sexual symptoms of menopause among Chinese women: a longitudinal study. Front Endocrinol (Lausanne). 2022;13:814872. doi: 10.3389/fendo.2022.814872.
   PubMed Web of Science ®Google Scholar
• Esposito K, Ciotola M, Giugliano F, et al. Association of body weight with sexual function in women. Int J Impot Res. 2007;19(4):353–357. doi: 10.1038/sj.ijir.3901548.
   PubMed Web of Science ®Google Scholar
• Faubion SS, Fairbanks F, Kuhle CL, et al. Association between body mass index and female sexual dysfunction: a cross-sectional study from the data registry on experiences of aging, menopause, and sexuality. J Sex Med. 2020;17(10):1971–1980. doi: 10.1016/j.jsxm.2020.07.004.
   PubMed Web of Science ®Google Scholar
• Rodríguez A, Ezquerro S, Méndez-Giménez L, et al. Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. Am J Physiol Endocrinol Metab. 2015;309(8):E691–714. doi: 10.1152/ajpendo.00297.2015.
   PubMed Web of Science ®Google Scholar
• Thurston RC, Chang Y, Mancuso P, et al. Adipokines, adiposity, and vasomotor symptoms during the menopause transition: findings from the Study of Women’s Health Across the Nation. Fertil Steril. 2013;100(3):793–800. doi: 10.1016/j.fertnstert.2013.05.005.
   PubMed Web of Science ®Google Scholar
• Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol. 2005;25(10):2062–2068. doi: 10.1161/01.ATV.0000183883.72263.13.
   PubMed Web of Science ®Google Scholar
• Maiorino MI, Bellastella G, Giugliano D, et al. From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome. J Endocrinol Invest. 2018;41(11):1249–1258. doi: 10.1007/s40618-018-0872-6.
   PubMed Web of Science ®Google Scholar
• Nappi R, Salonia A, Traish AM, et al. Clinical biologic pathophysiologies of women’s sexual dysfunction. J Sex Med. 2005;2(1):4–25. doi: 10.1111/j.1743-6109.2005.20102.x.
   PubMed Web of Science ®Google Scholar
• Maseroli E, Fanni E, Cipriani S, et al. Cardiometabolic risk and female sexuality: focus on clitoral vascular resistance. J Sex Med. 2016;13(11):1651–1661. doi: 10.1016/j.jsxm.2016.09.009.
   PubMed Web of Science ®Google Scholar
• Calmasini FB, Klee N, Webb RC, et al. Impact of immune system activation and vascular impairment on male and female sexual dysfunction. Sex Med Rev. 2019;7(4):604–613. doi: 10.1016/j.sxmr.2019.05.005.
   PubMed Web of Science ®Google Scholar
• Tsatsanis C, Dermitzaki E, Avgoustinaki P, et al. The impact of adipose tissue-derived factors on the hypothalamic-pituitary-gonadal (HPG) axis. Hormones (Athens). 2015;14(4):549–562. doi: 10.14310/horm.2002.1649.
   PubMedGoogle Scholar
• Schrauwen P, van Marken Lichtenbelt WD, Westerterp KR, et al. Effect of diet composition on leptin concentration in lean subjects. Metabolism. 1997;46(4):420–424. doi: 10.1016/s0026-0495(97)90059-7.
   PubMed Web of Science ®Google Scholar
• Smith JT, Acohido BV, Clifton DK, et al. KiSS-1 neurones are direct targets for leptin in the ob/ob mouse. J Neuroendocrinol. 2006;18(4):298–303. doi: 10.1111/j.1365-2826.2006.01417.x.
   PubMed Web of Science ®Google Scholar
• Childs GV, Odle AK, MacNicol MC, et al. The importance of leptin to reproduction. Endocrinology. 2021;162(2):bqaa204. doi: 10.1210/endocr/bqaa204.
   PubMed Web of Science ®Google Scholar
• Mills EG, Yang L, Abbara A, et al. Current perspectives on kisspeptins role in behaviour. Front Endocrinol (Lausanne). 2022;13:928143. doi: 10.3389/fendo.2022.928143.
   PubMed Web of Science ®Google Scholar
• Thurston L, Hunjan T, Ertl N, et al. Effects of kisspeptin administration in women with hypoactive sexual desire disorder: a randomized clinical trial. JAMA Netw Open. 2022;5(10):e2236131. doi: 10.1001/jamanetworkopen.2022.36131.
   PubMed Web of Science ®Google Scholar
• Goossens GH, Jocken JWE, Blaak EE. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol. 2021;17(1):47–66. doi: 10.1038/s41574-020-00431-8.
   PubMed Web of Science ®Google Scholar
• Moccia P, Belda-Montesinos R, Monllor-Tormos A, et al. Body weight and fat mass across the menopausal transition: hormonal modulators. Gynecol Endocrinol. 2022;38(2):99–104. doi: 10.1080/09513590.2021.2004395.
   PubMed Web of Science ®Google Scholar
• Davis SR, Robinson PJ, Moufarege A, et al. The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women. Clin Endocrinol (Oxf). 2012;77(4):541–547. doi: 10.1111/j.1365-2265.2011.04301.x.
   PubMed Web of Science ®Google Scholar
• Janssen I, Powell LH, Jasielec MS, et al. Covariation of change in bioavailable testosterone and adiposity in midlife women. Obesity (Silver Spring). 2015;23(2):488–494. doi: 10.1002/oby.20974.
   PubMed Web of Science ®Google Scholar
• Schmandt RE, Iglesias DA, Co NN, et al. Understanding obesity and endometrial cancer risk: opportunities for prevention. Am J Obstet Gynecol. 2011;205(6):518–525. doi: 10.1016/j.ajog.2011.05.042.
   PubMed Web of Science ®Google Scholar
• Cauley JA, Gutai JP, Kuller LH, et al. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol. 1989;129(6):1120–1131. doi: 10.1093/oxfordjournals.aje.a115234.
   PubMed Web of Science ®Google Scholar
• Lindau ST, Dude A, Gavrilova N, et al. Prevalence and correlates of vaginal estrogenization in postmenopausal women in the United States. Menopause. 2017;24(5):536–545. doi: 10.1097/GME.0000000000000787.
   PubMed Web of Science ®Google Scholar
• Goughnour SL, Thurston RC, Althouse AD, et al. Assessment of hot flushes and vaginal dryness among obese women undergoing bariatric surgery. Climacteric. 2016;19(1):71–76. doi: 10.3109/13697137.2015.1094782.
   PubMed Web of Science ®Google Scholar
• Bates JN, Pastuszak AW, Khera M. Effect of body weight on sexual function in men and women. Curr Sex Health Rep. 2019;11(1):52–59. doi: 10.1007/s11930-019-00192-0.
   PubMedGoogle Scholar
• Esfahani SB, Pal S. Obesity, mental health, and sexual dysfunction: a critical review. Health Psychol Open. 2018;5(2):2055102918786867. doi: 10.1177/2055102918786867.
   Web of Science ®Google Scholar
• de Wit L, Luppino F, van Straten A, et al. Depression and obesity: a meta-analysis of community-based studies. Psychiatry Res. 2010;178(2):230–235. doi: 10.1016/j.psychres.2009.04.015.
   PubMed Web of Science ®Google Scholar
• Maki PM, Kornstein SG, Joffe H, et al. Board of trustees for The North American Menopause Society (NAMS) and the Women and Mood Disorders Task Force of the National Network of Depression Centers. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause. 2018;25(10):1069–1085. doi: 10.1097/GME.0000000000001174.
   PubMed Web of Science ®Google Scholar
• Llaneza P, García-Portilla MP, Llaneza-Suárez D, et al. Depressive disorders and the menopause transition. Maturitas. 2012;71(2):120–130. doi: 10.1016/j.maturitas.2011.11.017.
   PubMed Web of Science ®Google Scholar
• Jones GL, Sutton A. Quality of life in obese postmenopausal women. Menopause Int. 2008;14(1):26–32. doi: 10.1258/mi.2007.007034.
   PubMedGoogle Scholar
• Fooladi E, Bell RJ, Davis SR. Management strategies in SSRI-associated sexual dysfunction in women at midlife. Climacteric. 2012;15(4):306–316. doi: 10.3109/13697137.2012.658461.
   PubMed Web of Science ®Google Scholar
• Gill H, Gill B, El-Halabi S, et al. Antidepressant medications and weight change: a narrative review. Obesity (Silver Spring). 2020;28(11):2064–2072. doi: 10.1002/oby.22969.
   PubMed Web of Science ®Google Scholar
• Stanford FC, Cena H, Biino G, et al. The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women’s Health Initiative. Menopause. 2020;27(10):1117–1125. doi: 10.1097/GME.0000000000001589.
   PubMed Web of Science ®Google Scholar
• Jannini EA, Nappi RE. Couplepause: a new paradigm in treating sexual dysfunction during menopause and andropause. Sex Med Rev. 2018;6(3):384–395. doi: 10.1016/j.sxmr.2017.11.002.
   PubMed Web of Science ®Google Scholar
• Mollaioli D, Ciocca G, Limoncin E, et al. Lifestyles and sexuality in men and women: the gender perspective in sexual medicine. Reprod Biol Endocrinol. 2020;18(1):10. doi: 10.1186/s12958-019-0557-9.
   PubMed Web of Science ®Google Scholar
• Westbury S, Oyebode O, van Rens T, et al. Obesity stigma: causes, consequences, and potential solutions. Curr Obes Rep. 2023;12(1):10–23. doi: 10.1007/s13679-023-00495-3.
   PubMed Web of Science ®Google Scholar
• Côté M, Bégin C. Review of the experience of weight-based stigmatization in romantic relationships. Curr Obes Rep. 2020;9(3):280–287. doi: 10.1007/s13679-020-00383-0.
   PubMed Web of Science ®Google Scholar
• Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006;91(8):2906–2912. doi: 10.1210/jc.2006-0594.
   PubMed Web of Science ®Google Scholar
• Miner M, Esposito K, Guay A, et al. Cardiometabolic risk and female sexual health: the Princeton III summary. J Sex Med. 2012;9(3):641–651; quiz 652. doi: 10.1111/j.1743-6109.2012.02649.x.
   PubMed Web of Science ®Google Scholar
• Trompeter SE, Bettencourt R, Barrett-Connor E. Metabolic syndrome and sexual function in postmenopausal women. Am J Med. 2016;129(12):1270–1277.e1. doi: 10.1016/j.amjmed.2016.03.039.
   PubMed Web of Science ®Google Scholar
• Dutra da Silva GM, Rolim Rosa Lima SM, Reis BF, et al. Prevalence of hypoactive sexual desire disorder among sexually active postmenopausal women with metabolic syndrome at a public hospital clinic in Brazil: a cross-sectional study. Sex Med. 2020;8(3):545–553. doi: 10.1016/j.esxm.2020.05.008.
   PubMed Web of Science ®Google Scholar
• Martelli V, Valisella S, Moscatiello S, et al. Prevalence of sexual dysfunction among postmenopausal women with and without metabolic syndrome. J Sex Med. 2012;9(2):434–441. doi: 10.1111/j.1743-6109.2011.02517.x.
   PubMed Web of Science ®Google Scholar
• Dombek K, Capistrano EJ, Costa AC, et al. Metabolic syndrome and sexual function in postmenopausal women. Arch Endocrinol Metab. 2016;60(6):545–553. doi: 10.1590/2359-3997000000194.
   PubMed Web of Science ®Google Scholar
• Politano CA, Valadares AL, Pinto-Neto A, et al. The metabolic syndrome and sexual function in climacteric women: a cross-sectional study. J Sex Med. 2015;12(2):455–462. doi: 10.1111/jsm.12749.
   PubMed Web of Science ®Google Scholar
• Yoldemir T, Garibova N, Atasayan K. The association between sexual dysfunction and metabolic syndrome among Turkish postmenopausal women. Climacteric. 2019;22(5):472–477. doi: 10.1080/13697137.2019.1580256.
   PubMed Web of Science ®Google Scholar
• Maseroli E, Scavello I, Vignozzi L. Cardiometabolic risk and female sexuality-part I. Risk factors and potential pathophysiological underpinnings for female vasculogenic sexual dysfunction syndromes. Sex Med Rev. 2018;6(4):508–524. doi: 10.1016/j.sxmr.2018.02.009.
   PubMed Web of Science ®Google Scholar
• Thong EP, Codner E, Laven JSE, et al. Diabetes: a metabolic and reproductive disorder in women. Lancet Diabetes Endocrinol. 2020;8(2):134–149. doi: 10.1016/S2213-8587(19)30345-6.
   PubMed Web of Science ®Google Scholar
• Maseroli E, Scavello I, Vignozzi L. Cardiometabolic risk and female sexuality-part II. Understanding (and overcoming) gender differences: the key role of an adequate methodological approach. Sex Med Rev. 2018;6(4):525–534. doi: 10.1016/j.sxmr.2018.03.004.
   PubMed Web of Science ®Google Scholar
• Angulo J, Hannan JL. Cardiometabolic diseases and female sexual dysfunction: animal studies. J Sex Med. 2022;19(3):408–420. doi: 10.1016/j.jsxm.2021.12.009.
   PubMed Web of Science ®Google Scholar
• Katainen RE, Engblom JR, Siirtola TJ, et al. Climacteric symptoms in middle-aged women with chronic somatic diseases. Maturitas. 2016;86:17–24. doi: 10.1016/j.maturitas.2016.01.005.
   PubMed Web of Science ®Google Scholar
• Rahmanian E, Salari N, Mohammadi M, et al. Evaluation of sexual dysfunction and female sexual dysfunction indicators in women with type 2 diabetes: a systematic review and meta-analysis. Diabetol Metab Syndr. 2019;11(1):73. doi: 10.1186/s13098-019-0469-z.
   PubMed Web of Science ®Google Scholar
• Fanfulla F, Camera A, Fulgoni P, et al. Sexual dysfunction in obese women: does obstructive sleep apnea play a role? Sleep Med. 2013;14(3):252–256. doi: 10.1016/j.sleep.2012.11.023.
   PubMed Web of Science ®Google Scholar
• Proserpio P, Marra S, Campana C, et al. Insomnia and menopause: a narrative review on mechanisms and treatments. Climacteric. 2020;23(6):539–549. doi: 10.1080/13697137.2020.1799973.
   PubMed Web of Science ®Google Scholar
• Kling JM, Manson JE, Naughton MJ, et al. Association of sleep disturbance and sexual function in postmenopausal women. Menopause. 2017;24(6):604–612. doi: 10.1097/GME.0000000000000824.
   PubMed Web of Science ®Google Scholar
• Lamerton TJ, Torquati L, Brown WJ. Overweight and obesity as major, modifiable risk factors for urinary incontinence in young to mid-aged women: a systematic review and meta-analysis. Obes Rev. 2018;19(12):1735–1745. doi: 10.1111/obr.12756.
   PubMed Web of Science ®Google Scholar
• Chilaka C, Toozs-Hobson P, Chilaka V. Pelvic floor dysfunction and obesity. Best Pract Res Clin Obstet Gynaecol. 2023;90:102389. doi: 10.1016/j.bpobgyn.2023.102389.
   PubMed Web of Science ®Google Scholar
• Garg A, Ellis LB, Love RL, et al. Vaginal microbiome in obesity and its impact on reproduction. Best Pract Res Clin Obstet Gynaecol. 2023;90:102365. doi: 10.1016/j.bpobgyn.2023.102365.
   PubMed Web of Science ®Google Scholar
• Pastore LM, Carter RA, Hulka BS, et al. Self-reported urogenital symptoms in postmenopausal women: Women’s Health Initiative. Maturitas. 2004;49(4):292–303. doi: 10.1016/j.maturitas.2004.06.019.
   PubMed Web of Science ®Google Scholar
• Lindau ST, Schumm LP, Laumann EO, et al. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007;357(8):762–774. doi: 10.1056/NEJMoa067423.
   PubMed Web of Science ®Google Scholar
• Lindau ST, Gavrilova N. Sex, health, and years of sexually active life gained due to good health: evidence from two US population based cross sectional surveys of ageing. BMJ. 2010;340(mar09 2):c810–c810. doi: 10.1136/bmj.c810.
   PubMedGoogle Scholar
• Al-Azzawi F, Bitzer J, Brandenburg U, et al. Therapeutic options for postmenopausal female sexual dysfunction. Climacteric. 2010;13(2):103–120. doi: 10.3109/13697130903437615.
   PubMed Web of Science ®Google Scholar
• Kingsberg SA, Adler B, Metropoulos J, et al. The yin and yang of GSM and low sexual desire. Climacteric. 2023;26(4):323–328. doi: 10.1080/13697137.2023.2194529.
   PubMed Web of Science ®Google Scholar
• Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143(21):e984–e1010. doi: 10.1161/CIR.0000000000000973.
   PubMed Web of Science ®Google Scholar
• Valenzuela PL, Carrera-Bastos P, Castillo-García A, et al. Obesity and the risk of cardiometabolic diseases. Nat Rev Cardiol. 2023;20(7):475–494. doi: 10.1038/s41569-023-00847-5.
   PubMed Web of Science ®Google Scholar
• Parish SJ, Simon JA, Davis SR, et al. International society for the study of women’s sexual health clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in women. J Sex Med. 2021;18(5):849–867. doi: 10.1016/j.jsxm.2020.10.009.
   PubMed Web of Science ®Google Scholar
• Balica AC, Cooper AM, McKevitt MK, et al. Dyspareunia related to GSM: association of total vaginal thickness via transabdominal ultrasound. J Sex Med. 2019;16(12):2038–2042. doi: 10.1016/j.jsxm.2019.08.019.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Ferdeghini F, Sampaolo P, et al. Clitoral circulation in postmenopausal women with sexual dysfunction: a pilot randomized study with hormone therapy. Maturitas. 2006;55(3):288–295. doi: 10.1016/j.maturitas.2006.04.014.
   PubMed Web of Science ®Google Scholar
• Kemp JVA, Kumar V, Saleem A, et al. Examining associations between women’s mental health and obesity. Psychiatr Clin North Am. 2023;46(3):539–549. doi: 10.1016/j.psc.2023.04.009.
   PubMed Web of Science ®Google Scholar
• Bray GA, Heisel WE, Afshin A, et al. The science of obesity management: an endocrine society scientific statement. Endocr Rev. 2018;39(2):79–132. doi: 10.1210/er.2017-00253.
   PubMed Web of Science ®Google Scholar
• Kapoor E, Collazo-Clavell ML, Faubion SS. Weight gain in women at midlife: a concise review of the pathophysiology and strategies for management. Mayo Clin Proc. 2017;92(10):1552–1558. doi: 10.1016/j.mayocp.2017.08.004.
   PubMed Web of Science ®Google Scholar
• Angelidi AM, Belanger MJ, Kokkinos A, et al. Novel noninvasive approaches to the treatment of obesity: from pharmacotherapy to gene therapy. Endocr Rev. 2022;43(3):507–557. doi: 10.1210/endrev/bnab034.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Tiranini L, Martini E, et al. Medical treatment of female sexual dysfunction. Urol Clin North Am. 2022;49(2):299–307. doi: 10.1016/j.ucl.2022.02.001.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Gardella B. What are the challenges in prescribing pharmacotherapy for female sexual dysfunctions? Expert Opin Pharmacother. 2019;20(7):777–779. doi: 10.1080/14656566.2019.1582644.
   PubMed Web of Science ®Google Scholar
• Simon JA, Kingsberg SA, Goldstein I, et al. Weight loss in women taking flibanserin for Hypoactive Sexual Desire Disorder (HSDD): insights Into potential mechanisms. Sex Med Rev. 2019;7(4):575–586. doi: 10.1016/j.sxmr.2019.04.003.
   PubMed Web of Science ®Google Scholar
• Kornstein SG, Simon JA, Apfel SC, et al. Effect of flibanserin treatment on body weight in premenopausal and postmenopausal women with hypoactive sexual desire disorder: a post hoc analysis. J Womens Health (Larchmt). 2017;26(11):1161–1168. doi: 10.1089/jwh.2016.6230.
   PubMed Web of Science ®Google Scholar
• Simon JA, Kingsberg SA, Portman D, et al. Prespecified and integrated subgroup analyses from the RECONNECT phase 3 studies of bremelanotide. J Womens Health (Larchmt). 2022;31(3):391–400. doi: 10.1089/jwh.2021.0225.
   PubMed Web of Science ®Google Scholar
• Spana C, Jordan R, Fischkoff S. Effect of bremelanotide on body weight of obese women: data from two phase 1 randomized controlled trials. Diabetes Obes Metab. 2022;24(6):1084–1093. doi: 10.1111/dom.14672.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Cucinella L. Advances in pharmacotherapy for treating female sexual dysfunction. Expert Opin Pharmacother. 2015;16(6):875–887. doi: 10.1517/14656566.2015.1020791.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Tiranini L, Cucinella L, et al. Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading? Expert Opin Pharmacother. 2023;24(1):135–143. doi: 10.1080/14656566.2022.2066997.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA) – results from an international survey. Climacteric. 2012;15(1):36–44. doi: 10.3109/13697137.2011.647840.
   PubMed Web of Science ®Google Scholar
• Kapoor E, Kling JM, Lobo AS, et al. Menopausal hormone therapy in women with medical conditions. Best Pract Res Clin Endocrinol Metab. 2021;35(6):101578. doi: 10.1016/j.beem.2021.101578.
   PubMed Web of Science ®Google Scholar
• Lobo RA, Gompel A. Management of menopause: a view towards prevention. Lancet Diabetes Endocrinol. 2022;10(6):457–470. doi: 10.1016/S2213-8587(21)00269-2.
   PubMed Web of Science ®Google Scholar
• Davis SR, Baber RJ. Treating menopause – MHT and beyond. Nat Rev Endocrinol. 2022;18(8):490–502. doi: 10.1038/s41574-022-00685-4.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Tiranini L, Martini E, et al. Different local estrogen therapies for a tailored approach to GSM. Climacteric. 2023;26(4):361–366. doi: 10.1080/13697137.2023.2218998.
   PubMed Web of Science ®Google Scholar
• Palacios S, Nappi RE, Cancelo MJ, et al. Expert opinion on the treatment of vulvovaginal atrophy with ospemifene based on new evidence. Climacteric. 2023;26(4):388–391. doi: 10.1080/13697137.2023.2190881.
   PubMed Web of Science ®Google Scholar
• Islam RM, Bell RJ, Green S, et al. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019;7(10):754–766. doi: 10.1016/S2213-8587(19)30189-5.
   PubMed Web of Science ®Google Scholar
• Davis SR, Baber R, Panay N, et al. Global consensus position statement on the use of testosterone therapy for women. Climacteric. 2019;22(5):429–434. doi: 10.1080/13697137.2019.1637079.
   PubMed Web of Science ®Google Scholar
• Nappi RE. Testosterone for women: green light for sex, amber light for health? Lancet Diabetes Endocrinol. 2019;7(10):738–739. doi: 10.1016/S2213-8587(19)30251-7.
   PubMed Web of Science ®Google Scholar
• Jannini EA. SM = SM: the interface of systems medicine and sexual medicine for facing non-communicable diseases in a gender-dependent manner. Sex Med Rev. 2017;5(3):349–364. doi: 10.1016/j.sxmr.2017.04.002.
   PubMed Web of Science ®Google Scholar
• Towe M, La J, El-Khatib F, et al. Diet and female sexual health. Sex Med Rev. 2020;8(2):256–264. doi: 10.1016/j.sxmr.2019.08.004.
   PubMed Web of Science ®Google Scholar
• Allen MS, Walter EE. Health-related lifestyle factors and sexual dysfunction: a meta-analysis of population-based research. J Sex Med. 2018;15(4):458–475. doi: 10.1016/j.jsxm.2018.02.008.
   PubMed Web of Science ®Google Scholar
• Kudesia R, Alexander M, Gulati M, et al. Dietary approaches to women’s sexual and reproductive health. Am J Lifestyle Med. 2021;15(4):414–424. doi: 10.1177/15598276211007113.
   PubMed Web of Science ®Google Scholar
• Longo M, Scappaticcio L, Caputo M, et al. Mediterranean diet in type 2 diabetes: an updated overview of pharmacological activities of cardiometabolic and reproductive outcomes. Curr Opin Pharmacol. 2021;60:27–33. doi: 10.1016/j.coph.2021.06.005.
   PubMed Web of Science ®Google Scholar
• Esposito K, Marfella R, Ciotola M, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292(12):1440–1446. doi: 10.1001/jama.292.12.1440.
   PubMed Web of Science ®Google Scholar
• Esposito K, Ciotola M, Giugliano F, et al. Mediterranean diet improves sexual function in women with the metabolic syndrome. Int J Impot Res. 2007;19(5):486–491. doi: 10.1038/sj.ijir.3901555.
   PubMed Web of Science ®Google Scholar
• Cano A, Marshall S, Zolfaroli I, et al. The Mediterranean diet and menopausal health: an EMAS position statement. Maturitas. 2020;139:90–97. doi: 10.1016/j.maturitas.2020.07.001.
   PubMed Web of Science ®Google Scholar
• Sánchez-Sánchez ML, García-Vigara A, Hidalgo-Mora JJ, et al. Mediterranean diet and health: a systematic review of epidemiological studies and intervention trials. Maturitas. 2020;136:25–37. doi: 10.1016/j.maturitas.2020.03.008.
   PubMed Web of Science ®Google Scholar
• Camajani E, Feraco A, Verde L, et al. Ketogenic diet as a possible non-pharmacological therapy in main endocrine diseases of the female reproductive system: a practical guide for nutritionists. Curr Obes Rep. 2023;12(3):231–249. doi: 10.1007/s13679-023-00516-1.
   PubMed Web of Science ®Google Scholar
• Mitchell GA, Kassovska-Bratinova S, Boukaftane Y, et al. Medical aspects of ketone body metabolism. Clin Invest Med. 1995;18(3):193–216.
   PubMed Web of Science ®Google Scholar
• Caprio M, Infante M, Moriconi E, et al. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). J Endocrinol Invest. 2019;42(11):1365–1386. doi: 10.1007/s40618-019-01061-2.
   PubMed Web of Science ®Google Scholar
• Castro AI, Gomez-Arbelaez D, Crujeiras AB, et al. Effect of a very low-calorie ketogenic diet on food and alcohol cravings, physical and sexual activity, sleep disturbances, and quality of life in obese patients. Nutrients. 2018;10(10):1348. doi: 10.3390/nu10101348.
   PubMed Web of Science ®Google Scholar
• Mastorakos G, Pavlatou M, Diamanti-Kandarakis E, et al. Exercise and the stress system. Hormones (Athens). 2005;4(2):73–89.
   PubMedGoogle Scholar
• Lorenz TA, Meston CM. Acute exercise improves physical sexual arousal in women taking antidepressants. Ann Behav Med. 2012;43(3):352–361. doi: 10.1007/s12160-011-9338-1.
   PubMed Web of Science ®Google Scholar
• Helmrich SP, Ragland DR, Leung RW, et al. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med. 1991;325(3):147–152. doi: 10.1056/NEJM199107183250302.
   PubMed Web of Science ®Google Scholar
• Elavsky S. Longitudinal examination of the exercise and self-esteem model in Middle-aged women. J Sport Exerc Psychol. 2010;32(6):862–880. doi: 10.1123/jsep.32.6.862.
   PubMed Web of Science ®Google Scholar
• Maseroli E, Rastrelli G, Di Stasi V, et al. Physical activity and female sexual dysfunction: a lot helps, but not too much. J Sex Med. 2021;18(7):1217–1229. doi: 10.1016/j.jsxm.2021.04.004.
   PubMed Web of Science ®Google Scholar
• Liu T, Chen S, Mielke GI, et al. Effects of exercise on vasomotor symptoms in menopausal women: a systematic review and meta-analysis. Climacteric. 2022;25(6):552–561. doi: 10.1080/13697137.2022.2097865.
   PubMed Web of Science ®Google Scholar
• Fausto DY, Leitão AE, Silveira J, et al. An umbrella systematic review of the effect of physical exercise on mental health of women in menopause. Menopause. 2023;30(2):225–234. doi: 10.1097/GME.0000000000002105.
   PubMed Web of Science ®Google Scholar
• Carcelén-Fraile MDC, Aibar-Almazán A, Martínez-Amat A, et al. Effects of physical exercise on sexual function and quality of sexual life related to menopausal symptoms in peri- and postmenopausal women: a systematic review. Int J Environ Res Public Health. 2020;17(8):2680. doi: 10.3390/ijerph17082680.
   PubMed Web of Science ®Google Scholar
• Gerber JR, Johnson JV, Bunn JY, et al. A longitudinal study of the effects of free testosterone and other psychosocial variables on sexual function during the natural traverse of menopause. Fertil Steril. 2005;83(3):643–648. doi: 10.1016/j.fertnstert.2004.08.028.
   PubMed Web of Science ®Google Scholar
• Hess R, Conroy MB, Ness R, et al. Association of lifestyle and relationship factors with sexual functioning of women during midlife. J Sex Med. 2009;6(5):1358–1368. doi: 10.1111/j.1743-6109.2009.01225.x.
   PubMed Web of Science ®Google Scholar
• Yim G, Ahn Y, Chang Y, et al. Prevalence and severity of menopause symptoms and associated factors across menopause status in Korean women. Menopause. 2015;22(10):1108–1116. doi: 10.1097/GME.0000000000000438.
   PubMed Web of Science ®Google Scholar
• Castillo-Hernández IM, Ward-Ritacco CL, Evans EM. Depressive symptoms, but not moderate-to-vigorous physical activity, impacts sexual well-being and menopause-specific quality of life in Middle-aged women. Women Health. 2023;63(5):346–358. doi: 10.1080/03630242.2023.2195959.
   PubMed Web of Science ®Google Scholar
• Aversa A, Bruzziches R, Francomano D, et al. Weight loss by multidisciplinary intervention improves endothelial and sexual function in obese fertile women. J Sex Med. 2013;10(4):1024–1033. doi: 10.1111/jsm.12069.
   PubMed Web of Science ®Google Scholar
• Chakhtoura M, Haber R, Ghezzawi M, et al. Pharmacotherapy of obesity: an update on the available medications and drugs under investigation. EClinicalMedicine. 2023;58:101882. doi: 10.1016/j.eclinm.2023.101882.
   PubMedGoogle Scholar
• Jensterle M, Podbregar A, Goricar K, et al. Effects of liraglutide on obesity-associated functional hypogonadism in men. Endocr Connect. 2019;8(3):195–202. doi: 10.1530/EC-18-0514.
   PubMed Web of Science ®Google Scholar
• La Vignera S, Condorelli RA, Calogero AE, et al. Sexual and reproductive outcomes in obese fertile men with functional hypogonadism after treatment with liraglutide: preliminary results. J Clin Med. 2023;12(2):672. doi: 10.3390/jcm12020672.
   PubMed Web of Science ®Google Scholar
• Saad B. A review of the anti-obesity effects of wild edible plants in the mediterranean diet and their active compounds: from traditional uses to action mechanisms and therapeutic targets. Int J Mol Sci. 2023;24(16):12641. doi: 10.3390/ijms241612641.
   PubMed Web of Science ®Google Scholar
• Yerevanian A, Soukas AA. Metformin: mechanisms in human obesity and weight loss. Curr Obes Rep. 2019;8(2):156–164. doi: 10.1007/s13679-019-00335-3.
   PubMed Web of Science ®Google Scholar
• Imprialos KP, Stavropoulos K, Doumas M, et al. Sexual dysfunction, cardiovascular risk and effects of pharmacotherapy. Curr Vasc Pharmacol. 2018;16(2):130–142. doi: 10.2174/1570161115666170609101502.
   PubMed Web of Science ®Google Scholar
• Krysiak R, Drosdzol-Cop A, Skrzypulec-Plinta V, et al. Sexual functioning and depressive symptoms in women with diabetes and prediabetes receiving metformin therapy: a pilot study. Exp Clin Endocrinol Diabetes. 2017;125(1):42–48. doi: 10.1055/s-0042-116594.
   PubMed Web of Science ®Google Scholar
• Liao J, Yin Y, Zhong J, et al. Bariatric surgery and health outcomes: an umbrella analysis. Front Endocrinol (Lausanne). 2022;13:1016613. doi: 10.3389/fendo.2022.1016613.
   PubMed Web of Science ®Google Scholar
• Oliveira CFA, Dos Santos PO, de Oliveira RA, et al. Changes in sexual function and positions in women with severe obesity after bariatric surgery. Sex Med. 2019;7(1):80–85. doi: 10.1016/j.esxm.2018.10.001.
   PubMed Web of Science ®Google Scholar
• Olivera CK, Herron DM, Kini SU, et al. Long-term quality of life and pelvic floor dysfunction after bariatric surgery. Am J Obstet Gynecol. 2012;207(5):431.e1-4–431.e4. doi: 10.1016/j.ajog.2012.06.041.
   PubMed Web of Science ®Google Scholar
• Loh HH, Shahar MA, Loh HS, et al. Female sexual dysfunction after bariatric surgery in women with obesity: a systematic review and meta-analysis. Scand J Surg. 2022;111(1):14574969211072395. doi: 10.1177/14574969211072395.
   Web of Science ®Google Scholar
• World Health Organization. 1st world report on ageing and health. Geneva: WHO; 2015.
   Google Scholar